SYNACT PHARMA AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.05 SEK | -2.02% |
|
-2.08% | -20.16% |
| Apr. 23 | Synact Pharma AB Announces Changes in Nomination Committee Ahead of the 2024 Annual General Meeting | CI |
| Mar. 20 | Sweden's SynAct Pharma Names New CEO | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 27.76M | - | - | - | - | - | |
| 55.07B | - | |||||
| 41.79B | ||||||
| 40.22B | ||||||
| 28.17B | ||||||
| 26.28B |
- Stock Market
- Equities
- SYNACT Stock
- Charts SynAct Pharma AB
- Sector Chart